{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:41:22Z","timestamp":1790185282562,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Lipoxygenases (LOXs) have essential roles in stroke, atherosclerosis, diabetes, and hypertension. 12\/15-LOX inhibition was shown to reduce infarct size and brain edema in the acute phase of experimental stroke. However, the significance of 12\/15-LOX on neuroinflammation, which has an essential role in the pathophysiology of stroke, has not been clarified yet.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, ischemia\/recanalization (I\/R) was performed by occluding the proximal middle cerebral artery (pMCAo) in mice. Either the 12\/15-LOX inhibitor (ML351, 50\u2009mg\/kg) or its solvent (DMSO) was injected i.p. at recanalization after 1\u2009h of occlusion. Mice were sacrificed at 6, 24, and 72-h after ischemia induction. Infarct volumes were calculated on Nissl-stained sections. Neurological deficit scoring was used for functional analysis. Lipid peroxidation was determined by the MDA assay, and the inflammatory cytokines IL-6, TNF-alpha, IL-1beta, IL-10, and TGF-beta were quantified by ELISA. The inflammasome proteins NLRP1 and NLRP3, 12\/15-LOX, and caspase-1 were detected with immunofluorescence staining.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Infarct volumes, neurological deficit scores, and lipid peroxidation were significantly attenuated in ML351-treated groups at 6, 24, and 72-h. ELISA results revealed that the pro-inflammatory cytokines IL-1beta, IL-6, and TNF-alpha were significantly decreased at 6-h and\/or 24-h of I\/R, while the anti-inflammatory cytokines IL-10 and TNF-alpha were increased at 24-h or 72-h of ML351 treatment. NLRP1 and NLRP3 immunosignaling were enhanced at three time points after I\/R, which were significantly diminished by the ML351 application. Interestingly, NLRP3 immunoreactivity was more pronounced than NLRP1. Hence, we proceeded to study the co-localization of NLRP3 immunoreactivity with 12\/15-LOX and caspase-1, which indicated that NLRP3 was co-localized with 12\/15-LOX and caspase-1 signaling. Additionally, NLRP3 was found in neurons at all time points but in non-neuronal cells 72\u2009h after I\/R.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These results suggest that 12\/15-LOX inhibition suppresses ischemia-induced inflammation in the acute and subacute phases of stroke via suppressing inflammasome activation. Understanding the mechanisms underlying lipid peroxidation and its associated pathways, like inflammasome activation, may have broader implications for the treatment of stroke and other neurological diseases characterized by neuroinflammation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fncel.2023.1277268","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T09:52:17Z","timestamp":1695808337000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["12\/15-lipoxygenase inhibition attenuates neuroinflammation by suppressing inflammasomes"],"prefix":"10.3389","volume":"17","author":[{"given":"Canan","family":"Cakir-Aktas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Bodur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge","family":"Yemisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"van Leyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Karatas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/jcbfm.2008.143","article-title":"Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice","volume":"29","author":"Abulafia","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/1747493019841242","article-title":"NLRP3 inflammasome in ischemic stroke: as possible therapeutic target","volume":"14","author":"Alishahi","year":"2019","journal-title":"Int. J. Stroke"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.4049\/jimmunol.1201516","article-title":"NLRP3 inflammasome activity is negatively controlled by miR-223","volume":"189","author":"Bauernfeind","year":"2012","journal-title":"J. Immunol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/01.str.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41419-021-04379-z","article-title":"NLPR3 inflammasome inhibition alleviates hypoxic endothelial cell death in vitro and protects blood-brain barrier integrity in murine stroke","volume":"13","author":"Bellut","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41419-023-05716-0","article-title":"The interaction between ferroptosis and inflammatory signaling pathways","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1093\/brain\/awad045","article-title":"Neuronal NLRP3 inflammasome mediates spreading depolarization-evoked trigeminovascular activation","volume":"146","author":"Chen","year":"2023","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1016\/j.bmc.2006.01.057","article-title":"Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases","volume":"14","author":"Deschamps","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2174\/1570159X16666180222155833","article-title":"The role of inflammatory response in stroke associated programmed cell death","volume":"16","author":"Duris","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion--from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat. Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e790","DOI":"10.1038\/cddis.2013.326","article-title":"Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke","volume":"4","author":"Fann","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s12035-017-0394-9","article-title":"Evidence that NF-kappaB and MAPK signaling promotes NLRP Inflammasome activation in neurons following ischemic stroke","volume":"55","author":"Fann","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbi.2020.12.009","article-title":"The NLRP3 inflammasome drives inflammation in ischemia\/reperfusion injury after transient middle cerebral artery occlusion in mice","volume":"92","author":"Franke","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00011-016-0981-7","article-title":"NLRP3 inflammasome: a promising target in ischemic stroke","volume":"66","author":"Gao","year":"2017","journal-title":"Inflamm. Res."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/STROKEAHA.108.534503","article-title":"Temporal and spatial dynamics of cerebral immune cell accumulation in stroke","volume":"40","author":"Gelderblom","year":"2009","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12974-018-1282-6","article-title":"Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia\/reperfusion injury","volume":"15","author":"Gong","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","article-title":"Type I interferon inhibits interleukin-1 production and inflammasome activation","volume":"34","author":"Guarda","year":"2011","journal-title":"Immunity"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2010.03.140","article-title":"Advances in eicosanoid research, novel therapeutic implications","volume":"396","author":"Haeggstrom","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat. Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s12035-014-8766-x","article-title":"Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice","volume":"51","author":"Ishrat","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2020.09.036","article-title":"Hypoxia inducible factor-1alpha (HIF-1alpha) mediates NLRP3 Inflammasome-dependent-Pyroptotic and apoptotic cell death following ischemic stroke","volume":"448","author":"Jiang","year":"2020","journal-title":"Neuroscience"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1161\/STROKEAHA.108.514927","article-title":"Protecting against cerebrovascular injury: contributions of 12\/15-lipoxygenase to edema formation after transient focal ischemia","volume":"39","author":"Jin","year":"2008","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.29399\/npa.23646","article-title":"12\/15-lipoxygenase as a therapeutic target in brain disorders","volume":"56","author":"Karatas","year":"2019","journal-title":"Noro Psikiyatr. Ars."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.brainres.2017.10.024","article-title":"Inhibiting 12\/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models","volume":"1678","author":"Karatas","year":"2018","journal-title":"Brain Res."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1021\/jm050639j","article-title":"Novel human lipoxygenase inhibitors discovered using virtual screening with homology models","volume":"49","author":"Kenyon","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/1871527320666210512013648","article-title":"Arachidonic acid metabolites in neurologic disorders","volume":"21","author":"Kursun","year":"2022","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/STROKEAHA.118.023620","article-title":"Extent of ischemic brain injury after thrombotic stroke is independent of the NLRP3 (NACHT, LRR and PYD domains-containing protein 3) Inflammasome","volume":"50","author":"Lemarchand","year":"2019","journal-title":"Stroke"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.it.2021.07.005","article-title":"Lipid regulation of NLRP3 inflammasome activity through organelle stress","volume":"42","author":"Liang","year":"2021","journal-title":"Trends Immunol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1089\/ars.2015.6615","article-title":"Nuclear factor E2-related Factor-2 negatively regulates NLRP3 Inflammasome activity by inhibiting reactive oxygen species-induced NLRP3 priming","volume":"26","author":"Liu","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/STROKEAHA.116.014790","article-title":"12\/15-lipoxygenase inhibition or knockout reduces warfarin-associated hemorrhagic transformation after experimental stroke","volume":"48","author":"Liu","year":"2017","journal-title":"Stroke"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ana.24070","article-title":"NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage","volume":"75","author":"Ma","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.3390\/ijms21186454","article-title":"Neuroinflammatory mechanisms in ischemic stroke: focus on Cardioembolic stroke, background, and therapeutic approaches","volume":"21","author":"Maida","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/cr.2013.6","article-title":"Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock","volume":"23","author":"Mao","year":"2013","journal-title":"Cell Res."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12975-015-0400-3","article-title":"Correcting for brain Swelling's effects on infarct volume calculation after middle cerebral artery occlusion in rats","volume":"6","author":"McBride","year":"2015","journal-title":"Transl. Stroke Res."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2006.08.002","article-title":"The inflammasome: first line of the immune response to cell stress","volume":"126","author":"Ogura","year":"2006","journal-title":"Cells"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5607\/en.2014.23.1.104","article-title":"A method for generating a mouse model of stroke: evaluation of parameters for blood flow, behavior, and survival [corrected]","volume":"23","author":"Park","year":"2014","journal-title":"Exp. Neurobiol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10072-001-8170-y","article-title":"Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients","volume":"22","author":"Perini","year":"2001","journal-title":"Neurol. Sci."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/ph15101168","article-title":"Molecular mechanisms of Inflammasome in ischemic stroke pathogenesis","volume":"15","author":"Puleo","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"108719","DOI":"10.1016\/j.intimp.2022.108719","article-title":"Mitochondrial DNA in NLRP3 inflammasome activation","volume":"108","author":"Qiu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1021\/jm401915r","article-title":"Potent and selective inhibitors of human reticulocyte 12\/15-lipoxygenase as anti-stroke therapies","volume":"57","author":"Rai","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1021\/jm1008852","article-title":"Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1","volume":"53","author":"Rai","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"147626","DOI":"10.1016\/j.brainres.2021.147626","article-title":"Baicalein ameliorates ischemic brain damage through suppressing proinflammatory microglia polarization via inhibiting the TLR4\/NF-kappaB and STAT1 pathway","volume":"1770","author":"Ran","year":"2021","journal-title":"Brain Res."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1161\/01.str.29.7.1454","article-title":"A model of transient unilateral focal ischemia with reperfusion in the P7 neonatal rat: morphological changes indicative of apoptosis","volume":"29","author":"Renolleau","year":"1998","journal-title":"Stroke"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.3791\/4038","article-title":"Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining","volume":"69","author":"Rousselet","year":"2012","journal-title":"J. Vis. Exp."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1432-1327.1998.2560364.x","article-title":"Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling","volume":"256","author":"Sailer","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"ref47","first-page":"3232","article-title":"Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells","volume":"8","author":"Tong","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.4155\/fmc.14.129","article-title":"The potential of 12\/15-lipoxygenase inhibitors in stroke therapy","volume":"6","author":"van Leyen","year":"2014","journal-title":"Future Med. Chem."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1161\/01.STR.0000249004.25444.a5","article-title":"Baicalein and 12\/15-lipoxygenase in the ischemic brain","volume":"37","author":"van Leyen","year":"2006","journal-title":"Stroke"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1021\/jm0201262","article-title":"Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase","volume":"45","author":"Whitman","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12974-021-02137-8","article-title":"Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke","volume":"18","author":"Xu","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ana.23734","article-title":"Inhibition of 12\/15-lipoxygenase as therapeutic strategy to treat stroke","volume":"73","author":"Yigitkanli","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"110151","DOI":"10.1016\/j.biopha.2020.110151","article-title":"Cepharanthine attenuates cerebral ischemia\/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12\/15-LOX signaling","volume":"127","author":"Zhao","year":"2020","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2023.1277268\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T09:52:22Z","timestamp":1695808342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2023.1277268\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":53,"alternative-id":["10.3389\/fncel.2023.1277268"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2023.1277268","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"article-number":"1277268"}}